BioPharma Archives - Insights

Genetic Testing for Pancreatitis

MCL Education — Wed, 03 Sep 2025 10:00:00 +0000

Register now – Nov. 12, 2025 - PACE/State of FL - Review known genetic predisposing factors to acute or chronic pancreatitis, as well as define who may benefit from genetic testing.

The post Genetic Testing for Pancreatitis appeared first on Insights.

Diagnostic ecosystem boosts access to timely Alzheimer’s disease testing

Barbara J. Toman — Mon, 21 Oct 2024 13:15:00 +0000

Mayo Clinic Laboratories has developed a cutting-edge suite of Alzheimer's disease testing. The newest assays use blood samples, avoiding the need for lumbar punctures to obtain cerebrospinal fluid. The testing suite exemplifies Mayo Clinic Laboratories' innovative business approach. As a platform company, Mayo Clinic is creating a diagnostics ecosystem to meet a wide range of testing needs and help physicians order the right tests for their patients.

The post Diagnostic ecosystem boosts access to timely Alzheimer’s disease testing appeared first on Insights.

Plasma Test Increases Access to Alzheimer’s Testing: Alicia Algeciras-Schimnich, Ph.D.

Luci Gens — Thu, 10 Oct 2024 13:00:00 +0000

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Alicia Algeciras-Schimnich, Ph.D., a professor of laboratory medicine and pathology at Mayo Clinic and co-director of the Clinical Immunoassay Laboratory. They discuss Mayo Clinic’s plasma test for detecting Alzheimer’s disease and how […]

The post Plasma Test Increases Access to Alzheimer’s Testing: Alicia Algeciras-Schimnich, Ph.D. appeared first on Insights.

Thermo Fisher Scientific: Illuminating rare cancer prognosis and improving patients’ lives

Robin Huiras-Carlson — Mon, 16 Sep 2024 13:00:00 +0000

Aiming to advance understanding of hard-to-predict gastroenteropancreatic neuroendocrine tumors (GEP-NETs), Thermo Fisher Scientific joined forces with Mayo Clinic and BioPharma Diagnostics to validate and gain U.S. regulatory clearance of a novel, automated assay aimed at detecting a biomarker associated with the progressive disease.

The post Thermo Fisher Scientific: Illuminating rare cancer prognosis and improving patients’ lives appeared first on Insights.

Neurology study validates Alzheimer’s assays

Luci Gens — Mon, 10 Jun 2024 12:00:00 +0000

Mayo Clinic Laboratories’ BioPharma Diagnostics team facilitates specimen collections and access to archived samples to support clinical trials and diagnostic validation projects that advance healthcare. In this collaboration example, learn how BioPharma Diagnostics helped a research healthcare company evaluate the clinical performance of three assays designed to aid in the diagnosis of Alzheimer’s disease and other causes of cognitive impairment.

The post Neurology study validates Alzheimer’s assays appeared first on Insights.

Oncology surveillance biomarker study enrolls patients and evaluates assay

Luci Gens — Mon, 27 May 2024 12:00:00 +0000

Mayo Clinic Laboratories’ BioPharma Diagnostics team supports companies from discovery to post-market in advancing their precision medicine initiatives. In this collaboration example, learn how BioPharma Diagnostics helped a biotech company complete a surveillance biomarker study to establish a cutoff for its assay developed to monitor the progression or regression of disease in patients with well-defined gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

The post Oncology surveillance biomarker study enrolls patients and evaluates assay appeared first on Insights.

Infectious disease test gains U.S. FDA approval

Luci Gens — Mon, 13 May 2024 12:00:00 +0000

An ideal testing partner will offer extensive expertise in assay development and analytical validation services, along with access to biospecimens. In this collaboration example, learn how Mayo Clinic Laboratories’ BioPharma Diagnostics team helped a musculoskeletal diagnostics company complete a prospective study to demonstrate its test’s performance in detecting periprosthetic joint infection (PJI) in synovial fluid.

The post Infectious disease test gains U.S. FDA approval appeared first on Insights.

Oral fluid offers an alternative specimen for controlled substance monitoring: Paul Jannetto, Ph.D.

Barbara J. Toman — Tue, 07 May 2024 13:00:00 +0000

Paul Jannetto, Ph.D., explains the advantages that Mayo Clinic Laboratories' oral fluid drug screening offers over typical urine tests. Oral samples are easier to collect and harder to adulterate.

The post Oral fluid offers an alternative specimen for controlled substance monitoring: Paul Jannetto, Ph.D. appeared first on Insights.

Gastrointestinal study collects and tests patient specimens at multiple touchpoints

Luci Gens — Mon, 29 Apr 2024 12:00:00 +0000

Mayo Clinic Laboratories’ BioPharma Diagnostics team collaborates with biopharmaceutical, diagnostic, and other research companies to offer a wide range of laboratory testing and biopharma support for all phases of clinical trials. In this collaboration example, learn how BioPharma Diagnostics helped an international diagnostics company complete a study of patients with liver cirrhosis with the goal of validating a specific serum metabolite constellation to detect early hepatocellular carcinoma (HCC) lesions in liver cirrhosis.

The post Gastrointestinal study collects and tests patient specimens at multiple touchpoints appeared first on Insights.

Innovative Alzheimer’s disease diagnostic tool unveiled

Luci Gens — Wed, 17 Apr 2024 12:00:00 +0000

Mayo Clinic Laboratories has marked a significant advancement in the fight against Alzheimer's disease with the introduction of an innovative diagnostic test. This noninvasive blood test accurately detects the p-Tau217 biomarker, indicative of amyloid beta accumulation in the brain. This test is set to transform the approach to Alzheimer's disease management, offering a convenient and less invasive alternative to traditional diagnostic methods.

The post Innovative Alzheimer’s disease diagnostic tool unveiled appeared first on Insights.